Article

Contact lenses effective for medication delivery, according to study

Drug-releasing contact lenses may provide correct and consistent dosages of medication for patients, according to findings published in Investigative Ophthalmology & Visual Science.

Rockville, MD-Drug-releasing contact lenses may provide correct and consistent dosages of medication for patients, according to findings published in Investigative Ophthalmology & Visual Science.

According to the study, several things counteract the effectiveness of medicine when traditional eye drops are used. Eye drops deliver initial overdose followed by an extended period of underdose, and only a minimal amount of the dose actually is absorbed by the eye, according to investigators.

“Compliance is the biggest issue addressed here,” said lead researcher Daniel Kohane, MD, PhD, of Children’s Hospital Boston and Harvard Medical School. “People need to be able to properly and easily give themselves medication at home.”

The artificial lens delivers a constant dose of the medication, which increases the effectiveness of the treatment, according to researchers. This ability is particularly important for glaucoma patients, who on average administer drops accurately at rates between 41% and 76%, they said.

The lens prototype may be fitted for any dosage of medicine and synced with a person’s current contact lens prescription.

This research was supported by the National Institutes of Health, Fight for Sight, the Johnson & Johnson Young Investigator Award, the Boston Keratoprosthesis Fund, and the Massachusetts Eye and Ear Infirmary.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.